AdVEGFAdenovirus Vector Containing Vascular Endothelial Growth Factor. A bioengineered vascular endothelial growth factor (VEGF) with mixed reviews in effecting therapeutic angiogenesis. It garnered positive results in the REVASC trial, which assessed VEGF’s effect on coronary arteries, but was not successful in RAVE, a trial which examined VEGF’s effect on blood flow in peripheral artery disease.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.